All Stories

  1. Circulating tumor cells: silent predictors of metastasis

    Article • F1000Research, August 2017, Faculty of 1000, Ltd.

    Lanlan Zhou

  2. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212

    Article • Cell Cycle, May 2017, Taylor & Francis

    Lanlan Zhou

  3. Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation

    Article • Cell Cycle, May 2017, Taylor & Francis

    Lanlan Zhou

  4. The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia

    Article • Cell Cycle, May 2017, Taylor & Francis

    Lanlan Zhou

  5. Discovery and clinical introduction of first-in-class imipridone ONC201

    Article • Oncotarget, November 2016, Impact Journals, LLC

    Lanlan Zhou

  6. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons

    Article • Current Colorectal Cancer Reports, April 2016, Springer Science + Business Media

    Lanlan Zhou

  7. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells

    Article • Oncotarget, January 2016, Impact Journals, LLC

    Lanlan Zhou

  8. Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy

    Article • Cancer Biology & Therapy, November 2015, Taylor & Francis

    Lanlan Zhou

  9. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Lanlan Zhou

  10. Acoustic separation of circulating tumor cells

    Article • Proceedings of the National Academy of Sciences, April 2015, Proceedings of the National Academy of Sciences

    Lanlan Zhou

  11. Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors

    Article • Cell Cycle, September 2012, Taylor & Francis

    Lanlan Zhou

  12. Extracellular protease imaging for cell mass tracking of xenografted human malignant pleural mesothelioma

    Article • Oncology Reports, June 2012, Spandidos Publications

    Lanlan Zhou

  13. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction

    Article • Cancer Biology & Therapy, August 2011, Taylor & Francis

    Lanlan Zhou

  14. FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy

    Article • International Journal of Oncology, April 2011, Spandidos Publications

    Lanlan Zhou

  15. In Vivo, Multimodal Imaging of B Cell Distribution and Response to Antibody Immunotherapy in Mice

    Article • PLOS One, May 2010, PLOS

    Lanlan Zhou

  16. Sorafenib inhibits ERK1/2 and MCL-1L phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma

    Article • Cancer Biology & Therapy, December 2009, Taylor & Francis

    Lanlan Zhou

  17. Multispectral Fluorescence Imaging

    Article • Journal of Nuclear Medicine, September 2009, Society of Nuclear Medicine

    Lanlan Zhou

  18. Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers

    Article • Biosensors and Bioelectronics, October 2004, Elsevier

    Lanlan Zhou, Prof. Qian Liu